An image-based, high-throughput screening assay for molecules that induce excess DNA replication in human cancer cells.
Previous studies have shown DNA re-replication can be induced in cells derived from human cancers under conditions in which it is not possible for cells derived from normal tissues. Because DNA re-replication induces cell death, this strategy could be applied to the discovery of potential anticancer therapeutics. Therefore, an imaging assay amenable to high-throughput screening was developed that measures DNA replication in excess of four genomic equivalents in the nuclei of intact cells and indexes cell proliferation. This assay was validated by screening a library of 1,280 bioactive molecules on both normal and tumor-derived cells where it proved more sensitive than current methods for detecting excess DNA replication. This screen identified known inducers of excess DNA replication, such as inhibitors of microtubule dynamics, and novel compounds that induced excess DNA replication in both normal and cancer cells. In addition, two compounds were identified that induced excess DNA replication selectively in cancer cells and one that induced endocycles selectively in cancer cells. Thus, this assay provides a new approach to the discovery of compounds useful for investigating the regulation of genome duplication and for the treatment of cancer.
National Institute of Child Health and Human Development, NIH, Bethesda, MD 20892-2753, USA.
Wenge
W
Zhu
Chrissie Y
CY
Lee
Ronald L
RL
Johnson
Jennifer
J
Wichterman
Ruili
R
Huang
Melvin L
ML
DePamphilis
D000970:Antineoplastic Agents / Q000145:classification / Q000494:pharmacology*; D016923:Cell Death / Q000187:drug effects; D045744:Cell Line, Tumor / Q000187:drug effects / Q000473:pathology; D049109:Cell Proliferation / Q000187:drug effects; D004261:DNA Replication / Q000187:drug effects*; D004221:Disulfiram / Q000494:pharmacology; D004354:Drug Screening Assays, Antitumor; D057166:High-Throughput Screening Assays / Q000379:methods*; D006801:Humans; D007211:Indoles / Q000494:pharmacology*; D009369:Neoplasms / Q000188:drug therapy* / Q000235:genetics* / Q000473:pathology; D010293:Pargyline / Q000031:analogs & derivatives / Q000494:pharmacology; D054852:Small Molecule Libraries / Q000032:analysis; D013449:Sulfonamides / Q000494:pharmacology*
D000970:Antineoplastic Agents; D007211:Indoles; C416927:SU 6656; D054852:Small Molecule Libraries; D013449:Sulfonamides; C094031:3-phenylpropargylamine; D010293:Pargyline; D004221:Disulfiram
Annu Rev Cell Dev Biol. 1997;13:513-609
9442882
Biochimie. 2008 Jun;90(6):947-56
18343230
Science. 1998 Nov 20;282(5393):1497-501
9822382
Cancer Res. 2008 Aug 15;68(16):6789-96
18701504
Chromosoma. 1998 Dec;107(6-7):486-90
9914381
Biochem Biophys Res Commun. 2001 Nov 30;289(2):586-90
11716515
Cancer. 2000 Sep 1;89(5):983-94
10964328
Mol Cancer Ther. 2004 Sep;3(9):1049-60
15367699
J Biomol Screen. 1999;4(2):67-73
10838414
J Pharmacol Exp Ther. 2009 Mar;328(3):796-806
19066341
FEBS J. 2007 Sep;274(18):4788-801
17697112
Int J Mol Med. 2008 Mar;21(3):281-90
18288374
Curr Opin Cell Biol. 2006 Jun;18(3):231-9
16650748
Nat Med. 1996 Jan;2(1):72-9
8564846
Cell Cycle. 2009 Sep 15;8(18):3025-38
19713760
Chem Biol Interact. 2001 Jan 30;130-132(1-3):81-91
11306033
Adv Exp Med Biol. 2010;676:73-91
20687470
Int J Cancer. 2006 Mar 15;118(6):1577-80
16206267
Blood. 2005 May 15;105(10):3875-8
15677565
Haematologica. 2007 Dec;92(12):1631-8
18055986
Mol Pharmacol. 2000 Mar;57(3):568-75
10692498
Biochem J. 2007 Dec 15;408(3):297-315
17850214
Cell Cycle. 2009 May 15;8(10):1501-9
19372757
Clin Cancer Res. 2009 Feb 15;15(4):1460-5
19228747
Mutat Res. 1991 May;248(1):45-50
2030712
Nat Rev Cancer. 2010 Mar;10(3):194-204
20147901
Oncogene. 2001 Jan 25;20(4):420-9
11313973
Cancer Lett. 2009 Apr 8;276(1):21-31
19046802
Genes Dev. 2008 Nov 1;22(21):3024-36
18981479
Cell Cycle. 2009 Nov 15;8(22):3688-94
19855177
Cancer Res. 2006 Nov 1;66(21):10425-33
17079463
Cancer Res. 1997 Mar 15;57(6):1013-9
9067261
Curr Med Chem. 2009;16(3):327-49
19149581
Proc Natl Acad Sci U S A. 2006 Aug 1;103(31):11473-8
16864780
Int J Biochem Cell Biol. 2006;38(12):2183-95
16931106
Cancer Cell. 2004 Sep;6(3):209-14
15380511
Cell Cycle. 2010 May;9(9):1792-801
20436289
Acta Histochem. 2010;112(1):62-71
19004483
Oncogene. 2000 Nov 9;19(47):5303-13
11103931
Mol Cell Biol. 2001 Oct;21(19):6529-36
11533241
Mol Cell Biol. 2000 Dec;20(23):9018-27
11074000
Cell Div. 2009 Jun 02;4:10
19490616
Gynecol Oncol. 2009 Oct;115(1):90-96
19577796
Clin Cancer Res. 2009 Oct 1;15(19):6070-8
19789329
Exp Cell Res. 2000 Nov 25;261(1):271-83
11082297
Proc Natl Acad Sci U S A. 2006 Jul 11;103(28):10660-5
16818887
Blood Cells Mol Dis. 2007 Jul-Aug;39(1):130-4
17434768
Carcinogenesis. 1999 Jul;20(7):1161-8
10383885
J Med Chem. 2010 Apr 8;53(7):2757-65
20222671
Cancer Res. 2009 Jun 1;69(11):4870-7
19487297
Protoplasma. 2006 May;227(2-4):147-53
16520877
Pharmacogenet Genomics. 2008 Nov;18(11):977-88
18806692
Neurotoxicology. 2010 Aug;31(4):367-72
20417232
Cell Cycle. 2002 Mar-Apr;1(2):143-52
12429924
Mol Cell Biol. 2009 Dec;29(24):6500-14
19822658
Assay Drug Dev Technol. 2006 Apr;4(2):209-21
16712425
Pathol Biol (Paris). 2000 Apr;48(3):246-54
10858957
Biochim Biophys Acta. 2008 Feb;1780(2):203-13
18029098
Exp Cell Res. 1999 Aug 1;250(2):339-50
10413588
Mutagenesis. 1998 Mar;13(2):193-8
9568594